$ASND news
The latest ASND stock news: headlines, filings, AI summaries and sentiment for $ASND, updated around the clock.
- Ascendis Pharma Reports Q3 Revenue Growth of 90.7% Year-over-Year
- Ascendis Pharma Authorizes $400 Million Share Buyback
- Ascendis Pharma Regains Rights to Metabolic Drug TransCon Semaglutide
- BioMarin Shares Rise After Reaching Patent Settlement with Ascendis
- BioMarin Secures Royalties on Ascendis' Yuviwel in Patent Settlement
- BioMarin and Ascendis Settle Global Patent Disputes Over Yuviwel
- Artisan Small Cap Fund Reduces Stake in Ascendis Pharma Amid Legal Concerns
- Ascendis Pharma Added to Multiple Russell U.S. Indexes
- Siren Fund Exits $52.87 Million Position in Ascendis Pharma
- Ascendis Financials for Q1 2026: Revenue and Operating Performance